Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/17/25 16:05 | 1/15/25 | PCVX | Health | BioPrd | Biological Products, (No Diag | Loxam Teri | CA | D | 1 | S.d | -532 | 85.11 | 0 | -6 | 7 | D | ||||||||||||||||
1/7/25 16:33 | 1/6/25 | PCVX | Health | BioPrd | Biological Products, (No Diag | Eydelman Mikhail | CA | O | SVP,GC,C | 3 | S.d | -1,417 | 94.48 | 0 | -15 | 29 | D | |||||||||||||||
1/3/25 18:07 | 1/2/25 | PCVX | Health | BioPrd | Biological Products, (No Diag | Wassil Jim | CA | O | COO | 3 | S.d | -2,264 | 94.32 | 0 | -24 | 206 | D | |||||||||||||||
12/19/24 16:07 | 12/18/24 | PCVX | Health | BioPrd | Biological Products, (No Diag | Guggenhime Andrew | CA | O | P,CFO | 3 | S.d | -6,243 | 107.64 | 0 | -58 | 109 | D | |||||||||||||||
12/10/24 16:10 | 12/9/24 | PCVX | Health | BioPrd | Biological Products, (No Diag | Pickering Grant | CA | DO | CEO | 4 | S.d | -3,453 | 99.42 | 0 | -35 | 725 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |